Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ranitidine (25mg) Injection
Therapeutic Category
Antacid, Gastroenterology
Dosage Form
Injection
Packaging Type
Ampule
Packaging
10x2ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ranilair 25 Injection containing Ranitidine is used for the management of acidity, gastric ulcers, and related gastrointestinal conditions. It helps in reducing stomach acid production and relieving symptoms like heartburn and irritation.
Ranitidine works by blocking histamine H2 receptors in the stomach, which decreases acid secretion and promotes healing of ulcers and gastric lining.
The injection is commonly used in hospitals and emergency care where rapid acid control is required, ensuring consistent demand and repeat usage across gastro and general medicine departments.
With increasing cases of gastric disorders and continuous hospital requirement, this product offers strong business potential for distributors and stockists. Its steady prescription demand, wide application, and frequent institutional use make it a fast-moving product that can drive consistent sales and growth in the gastro segment.
Some patients may experience headache, dizziness, constipation, or diarrhea. Rarely, allergic reactions, changes in liver enzymes, or cardiac effects such as bradycardia may occur and require medical attention.
Ranilair 25 Injection is indicated for the management of peptic ulcer disease, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and for the prevention of stress ulcers in critically ill patients. It helps reduce acidity, relieve heartburn, and support healing of the gastrointestinal tract.
This injection should be administered under medical supervision. Dose adjustment may be required in patients with kidney impairment. Inform your healthcare provider about any ongoing medications to avoid interactions.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.
Composition : Granisetron (1mg) Injection
Composition : Ondansetron (2mg)
Composition : Tigecycline (50mg) Injection
Composition : Teicoplanin (400mg) Injection
Composition : Teicoplanin (200mg) Injection
Composition : Polymyxin B (500000IU) Injection
Composition : Piperacillin (4000mg) + Tazobactum (500mg)
Composition : Piperacillin (2000mg) + Tazobactum (250mg)
Composition : Piperacillin (1000mg) + Tazobactum (125mg)
Composition : Meropenem (1000mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ranitidine 25mg/ml Injection has demand in the hospital care, gastroenterology, emergency medicine, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable gastrointestinal care portfolios.
Medical distributors and agencies can benefit from demand for acid-related gastrointestinal disorder management in hospital settings under medical supervision. Ranitidine 25mg/ml is an H2-receptor antagonist that helps reduce gastric acid secretion Commonly used in hospital settings for the management of acid-peptic disorders, gastric irritation, stress-related mucosal conditions, and other acid-related gastrointestinal conditions as per prevailing medical guidelines The injectable formulation provides rapid action when oral administration is not suitable Frequently utilized in hospitals, emergency departments, and critical care units Widely used by physicians, surgeons, gastroenterologists, and critical care specialists where appropriate This strengthens a comprehensive gastroenterology and hospital care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ranitidine 25mg/ml Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from institutional demand, hospital procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the injectable gastrointestinal care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.